由LIFUS驱动的工程细菌通过机械-NOTCH信号重新编程免疫抑制
Lizhou Lin1, Xiao Li1, Wenyun Guo1
1Department of Ultrasound, Institute of Ultrasound in Medicine and Engineering, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China.
Cell reports. Medicine
|March 10, 2026
概括
工程Salmonella细菌释放气囊 (GVs),当被聚焦超声波激活时,重塑固体瘤. 这种方法增强了T细胞的透和功能,改善了采用T细胞治疗的结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 生物医学工程 生物医学工程
背景情况:
- 固体瘤具有显著的树皮和免疫障碍,阻碍T细胞透和抗瘤活性.
- 目前的免疫疗法在克服复杂的瘤微环境 (TME) 方面面临着挑战.
研究的目的:
- 设计一种基于沙门氏菌的新型系统,用于TME的机械改造.
- 研究LIFUS激活GVs对T细胞功能和瘤控制的影响.
- 开发一种机械化启动策略,以增强采用性T细胞疗法.
主要方法:
- 改造的沙门氏菌VNP20009以表达气体囊泡 (GVs).
- 利用低强度聚焦超声波 (LIFUS) 激活GVs,在瘤内产生局部机械力.
- 进行单细胞RNA测序以分析T细胞状态和TME组成.
- 在临床前瘤模型中评估了机械启动方法的有效性.
主要成果:
- 激活LIFUS的GVs通过减少与癌症相关的纤维细胞 (CAFs) 和矩阵密度来重塑TME.
- 通过Notch1-Jagged1轴观察到CAF-CD8+T细胞通信的中断.
- 增强了内CD8+T细胞透,细胞毒性效应器功能和细胞因子的产生.
- 机械治疗改善了CD8+T细胞细胞毒性,减少了疲劳,并导致了持久的瘤控制和延长生存时间.
结论:
- 由LIFUS激活的GV为TME的生物力学改造提供了一个新的策略.
- 这种方法增强了T细胞透和效应器功能,克服了瘤诱导的免疫抑制.
- 用LIFUS驱动的GV进行机械启动,代表了采用T细胞疗法的有希望的增强.
相关概念视频
Transduction
2.3K
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
2.3K
Bacterial Signaling
42.7K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
42.7K
NF-κB-dependent Signaling Pathway
10.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.2K


